Skip to main content
Premium Trial:

Request an Annual Quote

Kenneth Buechler, Dirk van den Boom

Sequenom's board of directors has elected Kenneth Buechler its chairman, effective April 1. He succeeds Harry Hixson, who is retiring from the position after 11 years. Also, Dirk van den Boom was elected as a director, effective April 1.

Buechler has been on Sequenom's board since late 2009 and was previously president and CSO of Biosite, which he co-founded. Before that he was a senior research scientist for the diagnostics R&D group at Hybritech. 

Van den Boom is currently executive vice president and chief scientific and strategy officer at Sequenom. He will serve on the board's science committee.